全文获取类型
收费全文 | 430篇 |
免费 | 21篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 12篇 |
妇产科学 | 4篇 |
基础医学 | 78篇 |
口腔科学 | 2篇 |
临床医学 | 51篇 |
内科学 | 108篇 |
皮肤病学 | 3篇 |
神经病学 | 26篇 |
特种医学 | 6篇 |
外科学 | 63篇 |
综合类 | 3篇 |
预防医学 | 20篇 |
眼科学 | 4篇 |
药学 | 23篇 |
肿瘤学 | 48篇 |
出版年
2022年 | 4篇 |
2021年 | 5篇 |
2020年 | 8篇 |
2019年 | 8篇 |
2018年 | 4篇 |
2017年 | 8篇 |
2016年 | 17篇 |
2015年 | 6篇 |
2014年 | 10篇 |
2013年 | 19篇 |
2012年 | 16篇 |
2011年 | 26篇 |
2010年 | 16篇 |
2009年 | 12篇 |
2008年 | 26篇 |
2007年 | 20篇 |
2006年 | 25篇 |
2005年 | 25篇 |
2004年 | 32篇 |
2003年 | 31篇 |
2002年 | 23篇 |
2001年 | 7篇 |
2000年 | 6篇 |
1999年 | 11篇 |
1998年 | 8篇 |
1997年 | 7篇 |
1996年 | 4篇 |
1995年 | 2篇 |
1994年 | 5篇 |
1993年 | 3篇 |
1992年 | 4篇 |
1991年 | 3篇 |
1990年 | 5篇 |
1989年 | 3篇 |
1988年 | 2篇 |
1986年 | 6篇 |
1985年 | 5篇 |
1984年 | 5篇 |
1982年 | 1篇 |
1981年 | 3篇 |
1980年 | 3篇 |
1979年 | 1篇 |
1976年 | 2篇 |
1975年 | 1篇 |
1974年 | 2篇 |
1973年 | 1篇 |
1970年 | 1篇 |
1969年 | 4篇 |
1967年 | 1篇 |
1966年 | 3篇 |
排序方式: 共有452条查询结果,搜索用时 15 毫秒
1.
The Israel Maternal Perinatal Database (IMPD) includes the 1980–92 birth cohorts and was created using deterministic linkage, based on a unique identity number. This number is assigned at birth for Israeli-born infants and upon acquiring permanent or temporary residential status for immigrants and is used widely. The IMPD includes ≈1.3 million births and about 400000 mothers with more than one birth, 40 000 mothers with more than three births and 20 000 grand multipara mothers with four births or more. The pretest-based estimates of incorrectly matched births are 2%. The expected percentage of underlinkage is 5–10% for births occurring before 1985. Since 1985, incorrect maternal underlinkages result only when a birth occurs out of Israel to an Israeli resident. One of the advantages of the IMPD is the ability to estimate linkage reliability, validity and censoring effects by comparison with an external data source, the National Population Register, which groups each mother with all her living children under the age of 18 years. One of the potential analysis pitfalls is the effect of censoring at entry as a result of influx of immigrants from the former Soviet Union and Ethiopia. 相似文献
2.
3.
Comparison of positive allergy skin tests among asthmatic children from rural and urban areas living within small geographic area. 总被引:1,自引:0,他引:1
Haim Bibi David Shoseyov David Feigenbaum Pnina Nir Rosa Shiachi Shimon Scharff Ronit Peled 《Annals of allergy, asthma & immunology》2002,88(4):416-420
BACKGROUND: Evidence of increased asthma and allergic response among urban versus rural residents has been reported. OBJECTIVE: To evaluate the prevalence of allergic response among asthmatic children from urban and rural areas living within close proximity. METHODS: In all, 448 asthmatic children from urban (363) and rural (85) areas were studied. The study group consisted of 234 9-year-olds and 214 12-year-olds. A health questionnaire was completed on each child who subsequently underwent allergic skin prick tests (SPTs). RESULTS: There was significantly more positive SPT response to house-dust mite, mold, cat, and cypress among asthmatic children from urban areas compared with children living in rural areas: 58.3% versus 37.6%, 46.1% versus 31.8%, 17.45 versus 5.9%, and 26.2% versus 15.3%, respectively. Positive SPT for indoor allergens were significantly greater among asthmatic urban residents than asthmatic rural residents: 63.3% versus 45.5%, respectively (P < 0.02). Positive SPT response to all the allergens checked was higher among the 12-year-old age group when compared with the 9-year-olds, 34.6% versus 22.7%, respectively (P = 0.05). CONCLUSIONS: Allergic response measured by SPT is significantly more common among asthmatic children from urban areas as opposed to rural, even though both areas are within small distance of one another. Further, asthmatic children living in urban areas demonstrated more allergic response to both indoor and outdoor allergens. The allergic response tends to increase with increased age in both urban and rural asthmatic children. 相似文献
4.
B. S. Kamps H. -R. Brodt S. Staszewski L. Bergmann E. B. Helm 《Journal of molecular medicine (Berlin, Germany)》1994,72(4):283-287
The clinical history of 1538 HIV positive patients was analyzed on the basis of the new CDC classification system of HIV disease and AIDS. This classification system combines three CD4 cell categories (1, 2, and 3) with three clinical categories (A, B, and C) into nine subgroups AI–C3. We examined the overall survival for all subgroups and the AIDS-free survival for subgroups Al–B3. AIDS-free survival for patients in subgroups Al, A2, and B1 was considerably longer than survival in patients from subgroups A3, B2, and B3 (P < 0.0001). According to these findings, the new CDC classification system could be simplified into three stages, stage I and II comprising the above mentioned six subgroups, and stage III comprising clinical AIDS defining categories C1, C2, and C3. These three stages correspond to different periods in the management of HIV positive patients, i.e., period of observation, period of prophylaxis, and period of treatment.Abbreviations AIDS
acquired immunodeficiency syndrome
- CDC
Centers for Disease Control
- HIV
Human immunodeficiency virus
Correspondence to: E.B. Helm 相似文献
5.
Einat Rabinovitch Dror Harats Pnina Yaron Tamar Luvish Merav Lidar Ron Kedem Aviv Shaish Issahar Ben-Dov Avi Livneh 《Annals of allergy, asthma & immunology》2007,99(6):517-521
BACKGROUND: Asthma is an inflammatory airway disease caused by interaction between susceptibility genes and diverse environmental factors. In Israel, asthma seems to be familial and more severe in patients of Iraqi Jewish descent. On the other hand, asthma is less frequent in individuals with familial Mediterranean fever, an autoinflammatory disease prevalent in the Iraqi Jewish community and linked to mutations in the familial Mediterranean fever gene, designated MEFV. OBJECTIVES: To explore a possible role for mutated MEFV in the reduced susceptibility to asthma and to determine its expression in Israeli subjects of Iraqi origins. METHODS: Using a case-control approach, we studied the presence of the 3 most common MEFV mutations (M694V, V726A, and E148Q) in DNA samples from 75 patients with asthma and 45 asymptomatic first-degree relatives, all of Iraqi Jewish origin. The severity of asthma was evaluated using a published severity score. RESULTS: Eleven patients with asthma and 14 of their relatives carried 1 or 2 mutations in the MEFV gene, a carrier rate significantly lower in patients with asthma than in their first-degree relatives and in ethnically matched healthy individuals (P < .03 and P < .003, respectively). Carriers of MEFV mutations had less severe disease, compared with noncarriers (P < .002). CONCLUSION: These findings suggest that MEFV mutations may have a protective effect in the pathogenesis of asthma. 相似文献
6.
Oral administration of muscle derived small molecules inhibits tumor spread while promoting normal cell growth in mice 总被引:5,自引:0,他引:5
Bar-Yehuda S Farbstein T Barer F Ohana G Fishman P 《Clinical & experimental metastasis》1999,17(6):531-535
Tumor metastases are extremely rare in striated muscles. This is surprising given the fact that this tissue constitutes 60%
of body weight. The present study focuses on small molecules produced and secreted by muscle cells which possess anti-cancer
activity in vivo. Recently we have shown that a low molecular weight fraction (<1000 Dalton) of skeletal muscle cell conditioned medium (muscle
factor-MF), markedly inhibits the proliferation of carcinoma, sarcoma or melanoma cell lines in vitro. The MF exerts a cytostatic effect on tumor cell growth and arrests the cells in the G0/G1 of the cell cycle. However, normal
cell proliferation, such as bone marrow and fibroblasts, was stimulated following incubation with MF. In this study, the effect
of orally administered MF on melanoma and sarcoma growth was examined in mice. The administration of MF to mice inoculated
intravenously with melanoma (B16–F10) or sarcoma (MCA-105) cells, resulted in a statistically significant inhibition of metastatic
lung foci. In a different model, melanoma was induced in the foot pad and after development of a local lesion, the leg was
amputated. A prolonged survival time was observed in the MF treated groups. Since the MF stimulated bone marrow cell proliferation
in vitro, we decided to test its efficacy as an inhibitor of the myelotoxic effect exerted by chemotherapy, in vivo. MF, administered after chemotherapy, restored the number of white blood cells and yielded an increased percentage of neutrophils
compared with the decline in these parameters after administration of chemotherapy alone. Thus, it is indicated that MF exerted
a systemic anti tumor and chemoprotective effect when given orally. It can be concluded that it is bioavailable and is not
biodegradable in the digestive system. MF may be considered as a potential therapy for the prevention of tumor spread.
This revised version was published online in July 2006 with corrections to the Cover Date. 相似文献
7.
George J Barshack I Keren P Gazit A Levitzki A Keren G Roth A 《Experimental and molecular pathology》2005,78(3):233-238
BACKGROUND: Inflammation has been shown to play an important role in promoting the response to arterial injury and proinflammatory cytokines, such as tumor necrosis factor (TNF) alpha, are candidate mediators. AG-556 is a tyrosine kinase inhibitor proven to be effective in a model of multiple sclerosis-like syndrome in mice due to its immunomodulating effect. In the current study, we investigated the effect of the tyrphostin AG-556 on neointimal thickening and cytokine profile in a model of arterial injury in the mouse. METHODS: Injury was induced by external cuff placement on the left femoral artery of wild-type C57BL/6 mice. AG-556 dissolved in DMSO was injected intraperitoneally daily to the injured mice in a dosage of 2 mg/mouse. Control mice received DMSO injections. Histological analysis was carried out to assess neointimal formation. Splenocytes were cultured in the absence and presence of a mitogen for evaluation of thymidine incorporation and cytokine production. RESULTS: AG-556 treatment significantly attenuated intimal thickening (43,000+/-17,000 microm2; n=11) when compared to DMSO administration (286,000+/-127,000 microm2; n=10; P<0.05). Basal interferon-gamma production by splenocytes from AG-556-treated mice was increased by approximately 20-fold in comparison with levels in DMSO-treated animals, whereas Con-A induced secretion of the cytokine was similar between both groups. Levels of TNF-alpha, IL-4 and IL-10 in the culture supernatant from treated and non-treated animals did not differ significantly. CONCLUSION: The tyrosine kinase inhibitor AG-556 may have a role in the reduction of intimal thickening. The effect could be mediated via an immune modulating effect involving a significant increase in the smooth muscle cell inhibitory cytokine IFN-gamma. 相似文献
8.
Identification of a novel coronavirus in patients with severe acute respiratory syndrome 总被引:1,自引:0,他引:1
Drosten C Günther S Preiser W van der Werf S Brodt HR Becker S Rabenau H Panning M Kolesnikova L Fouchier RA Berger A Burguière AM Cinatl J Eickmann M Escriou N Grywna K Kramme S Manuguerra JC Müller S Rickerts V Stürmer M Vieth S Klenk HD Osterhaus AD Schmitz H Doerr HW 《The New England journal of medicine》2003,348(20):1967-1976
9.
Pnina Fishman Emily Falach-Vaknin Benjamin Sredni Piere Luigi Meroni Angela Tincani Dror Dicker Yehuda Shoenfeld 《American journal of reproductive immunology (New York, N.Y. : 1989)》1996,35(2):80-84
PROBLEM: Previously we reported on the generation of experimental anti-phospholipid syndrome (APS) in mice. These models were employed to evaluate the efficacy of various novel therapeutic modalities including interleukin-3 (IL-3) and low dose aspirin. The efficacy of the latter was found to be interrelated. Low dose aspirin is capable of inhibiting the activity of the enzyme cyclooxygenase which is responsible for the metabolism of arachidonic acid towards the production of prostaglandins. This shifts the metabolism of arachidonic acid to the other pathway and leads to an overproduction of leukotrienes. The leukotrienes act as stimulators of IL-3 production, a positive cytokine in pregnancy which enhances placental and fetal development. In the current study we evaluated the IL-3 levels in pregnant women with APS and expanded our knowledge on the interrelationships between aspirin, arachidonic acid metabolites and IL-3 in the human system. METHODS: IL-3 levels were recorded in the serum of pregnant women with APS and compared to a control pregnant group. In addition peripheral blood mononuclear cells from healthy subjects were incubated with different concentrations of aspirin or with arachidonic acid metabolites (Leukotriene B4, C4 or PGE2), and IL-3 production in the culture fluids was evaluated. RESULTS: Serum level of IL-3 in pregnant patients with primary APS, APS secondary to SLE and SLE was lower in comparison to the control group. The in vitro studies revealed that only low dose aspirin (10 mg/μl) stimulated IL-3 production while higher doses of the drug failed to induce the cytokine generation. Leukotriene B4 and C4 were stimulatory whereas PGE2 acted as inhibitor of IL-3 production. CONCLUSIONS: The serum level of IL-3 is decreased to pregnant women with primary or secondary APS. Low dose aspirin is capable of stimulating EL-3 production in vitro most probably through an elevation of leukotriene production, which may explain its beneficial activity in preventing the manifestations of APS. 相似文献
10.
G. Hunsmann J. Schneider H. Bayer R. Kurth A. Werner H. D. Brede V. Erfle W. Mellert H. R. Brodt L. Bergmann I. Helm I. Scharrer W. Kreuz H. Berthold P. Wernet E. M. Schneider K. Schimpf U. Egli U. Bienzle H. Schmitz P. Kern G. Krüger H. Rasokat E. Lechler E. Seifried P. Hellstern W. Schneider E. Holzer F. -D. Goebel R. Hehlmann 《Journal of molecular medicine (Berlin, Germany)》1985,63(5):233-235
Summary In 1984 10,281 sera were collected in the FRG and examined for antibodies to HTLV-III (LAV) with an enzyme-linked immunosorbent assay and confirmative tests. Of the German AIDS patients 81% have antibodies. Individuals belonging to AIDS risk groups, homosexuals, haemophiliacs and i.v. drug abusers, have antibody frequencies between 25%–72%. The detection of HTLV-III antibodies in blood donours indicates that the virus is being transmitted by blood transfusions.Abbreviations AIDS
acquired immunodeficiency syndrome
- LAS
lymphadenopathy syndrome
- ARC
AIDS related complex
- LAV
lymphadenopathy associated virus
- HTLV-III
human T-lymphotropic virus type III
- HBV
hepatitis B virus 相似文献